Amanda

Five Hospitalizations, a Pseudocyst, and Finally Some Answers: My Pancreatitis Story

Amanda knew something was different. After 13 years of living with Ulcerative Colitis, she knew these pains were not the same. What followed was months of misdiagnosis, five more hospitalizations, and a long road to finally being diagnosed with chronic pancreatitis and EPI. This is her story.

Five Hospitalizations, a Pseudocyst, and Finally Some Answers: My Pancreatitis Story Read More »

Autoimmune Pancreatitis Webinar Q&A

At a recent Mission: Cure patient education webinar, Dr. Yasmin Hernandez-Barco of Massachusetts General Hospital and Harvard Medical School, joined by Katharine Provencher of the IgG4ward! Foundation, walked attendees through the essentials of autoimmune pancreatitis (AIP): what it is, how it’s diagnosed, and what treatment options are available today. The conversation sparked so many great

Autoimmune Pancreatitis Webinar Q&A Read More »

Mission: Cure Announces Partnership With Cibus Therapeutics and Greenstone Biosciences to Advance a New Anti-Inflammatory Treatment for Chronic Pancreatitis

December 2025 — Mission: Cure is pleased to announce a collaboration with Cibus Therapeutics and Greenstone Biosciences, two biotechnology companies working together developing next-generation treatments for pancreatic and gastrointestinal diseases. This partnership reflects Mission: Cure’s commitment to keeping the patient community informed about emerging science and supporting efforts to advance new therapies for chronic pancreatitis.

Mission: Cure Announces Partnership With Cibus Therapeutics and Greenstone Biosciences to Advance a New Anti-Inflammatory Treatment for Chronic Pancreatitis Read More »

A Community for People Navigating High Triglycerides

High triglyceride levels can affect people in different ways. High triglycerides often don’t cause symptoms, so many people don’t realize their levels are elevated until a blood test. When triglycerides get extremely high, they can sometimes cause physical signs (like small yellow skin bumps) and can raise the risk of serious complications, including acute pancreatitis

A Community for People Navigating High Triglycerides Read More »

FDA Approves New Treatment for Familial Chylomicronemia Syndrome (FCS)

We have some exciting news for people living with pancreatitis caused by the FCS genetic mutation. The FDA has approved REDEMPLO® (plozasiran), a new treatment from Arrowhead Pharmaceuticals that lowers triglycerides and reduces acute pancreatitis attacks in adults with Familial Chylomicronemia Syndrome (FCS). This is an important step for people with FCS and a meaningful

FDA Approves New Treatment for Familial Chylomicronemia Syndrome (FCS) Read More »

Scroll to Top

Before You Go

Get Updates in Your Inbox

Stay up-to-date on the latest Mission: Cure news and developments in pancreatitis care.







I am a...: